304360 — S Biomedics Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩446bn
- KR₩455bn
- KR₩13bn
Annual cashflow statement for S Biomedics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | Annual Audited Accounts |
| Standards: | — | — | — | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -8,594 | -5,249 | -5,210 | -6,337 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 1,372 | 1,390 | 2,070 | 1,321 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,847 | 436 | -877 | -1,557 | -2,583 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6,847 | -5,437 | -3,287 | -3,205 | -6,149 |
| Capital Expenditures | -553 | -189 | -490 | -1,108 | -1,847 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2,445 | 8,978 | -3,500 | -5,763 | -6,976 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,891 | 8,788 | -3,990 | -6,871 | -8,824 |
| Financing Cash Flow Items | -152 | 144 | 75.6 | 853 | -809 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5,719 | 2,432 | 4,161 | 8,020 | 12,318 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 758 | 5,763 | -3,057 | -2,066 | -2,656 |